Data from PML-RARα and Its Phosphorylation Regulate PML Oligomerization and HIPK2 Stability

<div>Abstract<p>The <i>PML</i> gene is frequently fused to the <i>retinoic acid receptor α</i> (<i>RARα</i>) gene in acute promyelocytic leukemia (APL), generating a characteristic <i>PML-RARα</i> oncogenic chimera. PML-RARα disrupts the discrete nuclear speckles termed nuclear bodies, which are formed in PML, suggesting that nuclear body disruption is involved in leukemogenesis. Nuclear body formation that relies upon PML oligomerization and its stabilization of the hypoxia-inducible protein kinase (HIPK)-2 is disrupted by expression of the PML-RARα chimera. Here, we report that disruption of nuclear bodies is also mediated by PML-RARα inhibition of PML oligomerization. PKA-mediated phosphorylation of PML-RARα blocked its ability to inhibit PML oligomerization and destabilize HIPK2. Our results establish that both PML oligomerization and HIPK2 stabilization at nuclear bodies are important for APL cell differentiation, offering insights into the basis for the most common prodifferentiation therapies of APL used clinically. <i>Cancer Res; 73(14); 4278–88. ©2013 AACR</i>.</p></div>